Teva Announces Launch of Generic Epzicom® Tablets in the United States
Charles River Laboratories Acquires Agilux Laboratories, Inc.
GSK and Oncodesign Announce Agreement for Oncodesign’s Acquisition of GSK’s Research Centre in France
PAREXEL Announces Execution of Definitive Agreement to Acquire ExecuPharm
Walgreens Boots Alliance Provides Update on its Pending Acquisition of Rite Aid
Cerulean Cuts Work Force by Nearly Half
Cerulean Pharma Inc., a clinical-stage company developing nanoparticle-drug conjugates (NDCs), announced that it is reducing its workforce by approximately 48 percent, to a total of 23 full-time equivalent employees, under a plan expected to be substantially completed by the end of 2016. This workforce reduction is designed to reduce operating expenses while the company refocuses…
CDMO Ash Stevens to Be Acquired by Piramal Enterprises
Piramal Enterprises Limited announced that its wholly owned subsidiary in the U.S. has entered into an agreement to acquire 100 percent stake in Ash Stevens Inc., a U.S.-based contract development and manufacturing organization (CDMO), in an all cash deal for a consideration of USD $42.95 million plus an earn-out consideration capped at $10 million. This…
Class Action Lawsuit Filed Against Keryx Biopharmaceuticals
Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who acquired Keryx Biopharmaceuticals, Inc. securities between February 25, 2016 and August 1, 2016. The complaint filed in this lawsuit alleges…
Steroid-Releasing Implant for Patients with Chronic Sinus Disease
Intersect ENT, Inc., a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, announced that the company has submitted a supplemental premarket approval submission (PMA-s) to the FDA to seek approval for its new NOVA steroid-releasing implant for patients with chronic sinus disease. NOVA’s unique hourglass shape and…